Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
暂无分享,去创建一个
P. Grigsby | D. Mutch | J. Rader | B. Siegel | P. Thaker | F. Dehdashti | M. Powell | R. Brooks
[1] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[2] P. Grigsby,et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. , 2007, JAMA.
[3] A. Gadducci,et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. , 2007, Gynecologic oncology.
[4] P. Grigsby. The role of FDG-PET/CT imaging after radiation therapy. , 2007, Gynecologic oncology.
[5] A. Gadducci,et al. Follow-up strategies in gynecological oncology: searching appropriateness , 2007, International Journal of Gynecologic Cancer.
[6] H. Chung,et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. , 2006, Gynecologic oncology.
[7] B. Cheson,et al. Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.
[8] P. Grigsby,et al. Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography , 2005, Cancer.
[9] J. Unger,et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. , 2004, Gynecologic oncology.
[10] Imran Zoberi,et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Haie-meder,et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Berchuck,et al. The role of PET scanning in the detection of recurrent cervical cancer. , 2003, Gynecologic oncology.
[13] C. Choi,et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] P. Grigsby,et al. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. , 2002, International journal of radiation oncology, biology, physics.
[15] M. Plummer,et al. Strategies for HPV prevention. , 2002, Virus research.
[16] F Dehdashti,et al. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Wharton,et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. , 2000, Gynecologic oncology.
[18] R L Wahl,et al. Evaluation of FDG PET in patients with cervical cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[20] N. Breslow. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .